On June 7-9th Strainprint participated in O’Cannabiz as a platinum sponsor. The weekend was filled with insightful panels, productive industry discussions, and invaluable networking! Have a look at our round-up from the action-packed weekend below! We look foward to next year!
We are proud to present the genesis of Strainprint. Steph’s story is what defines us. With her story, and 1,000’s more like it we will continue to break the stigma & pave the way for the future of the cannabis industry. Have a look at Steph’s story, and if it resonates with you, consider sharing! […]
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]
Whether you are a medical cannabis patient or a recreational user, tracking your cannabis consumption habits are not only essential but also largely beneficial. Some people find it helpful to chronical their treatment journey in a paper-based journal but often find it inconvenient to capture each interaction and thus have an inaccurate record of […]
February 23, 2018 – Strainprint Founder Stephanie Karasick was featured in Her Canna Life High-Minded Women Q&A
Our Founder, Stephanie Karasick was recently profiled in HIGH Canada’s Women and Weed feature. Here she shares her personal medical cannabis journey, which was the genesis of the Strainprint App. Her full story can be found on page 58 of the December Edition.
National Post – Open Letter To ACMPR Medical Cannabis Patients Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post, share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.